FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bridgette Collins-Burow

Research Profile

Anatomy

Disorders

Breast Neoplasms

Chemicals & Drugs

Physiology

Procedures

Xenograft Model Antitumor Assays

Living Beings

Co-author Network

Publications

TOP 3
Bridgette M Collins-Burow; Tyler J Curiel; Steven Elliott; Daniel E Frigo; John A McLachlan; Christopher B Weldon; Jawed Alam; James W Antoon; Barbara S Beckman; Stephen M Boue; Matthew E Burow
Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.
Melyssa R Bratton; Jawed Alam; James W Antoon; Barbara S Beckman; Bridgette M Collins-Burow; Bich N Duong; Steven Elliott; Daniel E Frigo; Steven M Hill; Ling Lai; John A McLachlan; Lilia I Melnik; Brian G Rowan; Yan Tang; Syreeta Tilghman; Matthew E Burow
Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.
Elizabeth C Martin; Lyndsay Vanhoy Rhodes; Syreeta L Tilghman; Yun Zhu; Melyssa R Bratton; Bridgette M Collins-Burow; Matthew E Burow
Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bridgette Collins-Burow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Bridgette M Collins-Burow; Tyler J Curiel; Steven Elliott; Daniel E Frigo; John A McLachlan; Christopher B Weldon; Jawed Alam; James W Antoon; Barbara S Beckman; Stephen M Boue; Matthew E Burow
Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.
The Journal of steroid biochemistry and molecular biology 2012;132(1-2):186-93.
2012: Melyssa R Bratton; Jawed Alam; James W Antoon; Barbara S Beckman; Bridgette M Collins-Burow; Bich N Duong; Steven Elliott; Daniel E Frigo; Steven M Hill; Ling Lai; John A McLachlan; Lilia I Melnik; Brian G Rowan; Yan Tang; Syreeta Tilghman; Matthew E Burow
Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.
The Journal of endocrinology 2012;214(1):45-54.
2012: Elizabeth C Martin; Lyndsay Vanhoy Rhodes; Syreeta L Tilghman; Yun Zhu; Melyssa R Bratton; Bridgette M Collins-Burow; Matthew E Burow
Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line.
PloS one 2012;7(11):e49067.
2012: Chandra R Tate; Matthew Burow; Jennifer L Driver; F Nell Pounder; Lyndsay Vanhoy Rhodes; Chris Segar; Bridgette M Collins-Burow
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
Breast cancer research : BCR 2012;14(3):R79.
2012: Changhua Zhou; Qiang Zhang; Qiu Zhong; Melyssa R Bratton; Matthew Burow; Bridgette M Collins-Burow; Steven Elliott; Elizabeth C Martin; Lyndsay Vanhoy Rhodes; Ian Townley; Guangdi Wang
Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.
Breast cancer research : BCR 2012;14(2):R45.
2012: Lyndsay Vanhoy Rhodes; Chris Segar; Matthew E Burow; Jennifer L Driver; Steven Elliott; Meng Li; Elizabeth C Martin; Seung Yoon Nam; Kenneth P Nephew; Ashley M Nitschke; Bridgette M Collins-Burow
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.
Oncology reports 2012;27(1):10-6.
2011: Lyndsay Vanhoy Rhodes; Virgilio A Salvo; Chandra R Tate; Syreeta L Tilghman; Yun Zhu; Bridgette M Collins-Burow; Steven Elliott; Shannon E Muir; Kenneth P Nephew; Melyssa R Bratton; Matthew E Burow
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
Experimental cell research 2011;317(18):2573-81.
2011: Lyndsay Vanhoy Rhodes; Sarah P Short; Nicole F Neel; Virgilio A Salvo; Yun Zhu; Steven Elliott; Yongkun Wei; Dihua Yu; Menghong Sun; Shannon E Muir; Juan P Fonseca; Melyssa R Bratton; Chris Segar; Syreeta Latatia Tilghman; Tammy Sobolik-Delmaire; Linda W Horton; Snjezana Zaja-Milatovic; Bridgette M Collins-Burow; Scott Wadsworth; Barbara S Beckman; Charles E Wood; Suzanne A W Fuqua; Kenneth P Nephew; Paul Dent; Rebecca A Worthylake; Tyler J Curiel; Mien-Chie Hung; Ann Richmond; Matthew Burow
Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.
Cancer research 2011;71(2):603-13.
2010: Quan Jiang; FLORASTINA STEWART; Steven Elliott; Jennifer Driver; Lyndsay Vanhoy Rhodes; Qiang Zhang; Shilong Zheng; Deepak Bhatnagar; Stephen M Boue; Bridgette M Collins-Burow; Jayalakshmi Sridhar; Cheryl Stevens; john alan mclachlan; Thomas E Wiese; Matthew E Burow; Guangdi Wang
Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.
Journal of medicinal chemistry 2010;53(16):6153-63.
2010: M Carla Zimmermann; Syreeta Latatia Tilghman; Stephen M Boué; Virgilio A Salvo; Steven Elliott; K Y Williams; Elena V Skripnikova; Hasina Ashe; FLORASTINA STEWART; Lyndsay Vanhoy Rhodes; Juan Pablo Fonseca; Cynthia Corbitt; Bridgette M Collins-Burow; Melanie H Howell; Michelle Lacey; Betty Y Shih; Carol H Carter-Wientjes; Thomas E Cleveland; john alan mclachlan; Thomas E Wiese; Barbara S Beckman; Matthew Burow
Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy.
The Journal of pharmacology and experimental therapeutics 2010;332(1):35-45.
2006: Virgilio A Salvo; Stephen M Boué; Juan P Fonseca; Steven Elliott; Cynthia Corbitt; Bridgette M Collins-Burow; Tyler J Curiel; Sudesh K Srivastav; Betty Y Shih; Carol H Carter-Wientjes; Charles E Wood; Paul W Erhardt; Barbara S Beckman; john alan mclachlan; Thomas E Cleveland; Matthew Burow
Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7159-64.
2006: Daniel E Frigo; Aninda Basu; Erica N Nierth-Simpson; Christopher B Weldon; Christine M Dugan; Steven Elliott; Bridgette M Collins-Burow; Virgilio A Salvo; Yun Zhu; Lilia I Melnik; Gabriela N Lopez; Peter J Kushner; Tyler J Curiel; Brian G Rowan; john alan mclachlan; Matthew Burow
p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1.
Molecular endocrinology (Baltimore, Md.) 2006;20(5):971-83.
2005: Christopher B Weldon; Amy McKee; Bridgette M Collins-Burow; Lilia I Melnik; Aline B Scandurro; john alan mclachlan; Matthew Burow; Barbara S Beckman
PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling.
International journal of oncology 2005;26(3):763-8.
2002: Daniel E Frigo; Bich N Duong; Lilia I Melnik; Lawanda S Schief; Bridgette M Collins-Burow; Daniel K Pace; john alan mclachlan; Matthew Burow
Flavonoid phytochemicals regulate activator protein-1 signal transduction pathways in endometrial and kidney stable cell lines.
The Journal of nutrition 2002;132(7):1848-53.
2001: Matthew Burow; Stephen M Boue; Bridgette M Collins-Burow; Lilia I Melnik; Bich N Duong; Carol H Carter-Wientjes; Shuanfang Li; T E Wiese; Thomas E Cleveland; john alan mclachlan
Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta.
The Journal of clinical endocrinology and metabolism 2001;86(4):1750-8.
2000: Matthew Burow; Christopher B Weldon; Tung-Chin Chiang; Yan Tang; Bridgette M Collins-Burow; Kevin W Rolfe; Shuanfang Li; john alan mclachlan; Barbara S Beckman
Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants.
International journal of oncology 2000;16(6):1179-87.
2000: Matthew Burow; Christopher B Weldon; Lilia I Melnik; Bich N Duong; Bridgette M Collins-Burow; Barbara S Beckman; john alan mclachlan
PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis.
Biochemical and biophysical research communications 2000;271(2):342-5.
2000: Matthew Burow; Christopher B Weldon; Bridgette M Collins-Burow; N Ramsey; A McKee; A Klippel; john alan mclachlan; Sanda Clejan; Barbara S Beckman
Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions.
The Journal of biological chemistry 2000;275(13):9628-35.
2000: Bridgette M Collins-Burow; Matthew Burow; Bich N Duong; john alan mclachlan
Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
Nutrition and cancer 2000;38(2):229-44.
1999: Matthew Burow; Yan Tang; Bridgette M Collins-Burow; S Krajewski; J C Reed; john alan mclachlan; Barbara S Beckman
Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells.
Carcinogenesis 1999;20(11):2057-61.